FI970114A0 - NO-syntaasia koodaavan geenin käsittävä adenovirus - Google Patents

NO-syntaasia koodaavan geenin käsittävä adenovirus

Info

Publication number
FI970114A0
FI970114A0 FI970114A FI970114A FI970114A0 FI 970114 A0 FI970114 A0 FI 970114A0 FI 970114 A FI970114 A FI 970114A FI 970114 A FI970114 A FI 970114A FI 970114 A0 FI970114 A0 FI 970114A0
Authority
FI
Finland
Prior art keywords
adenovirus
synthase
gene encoding
gene
encoding
Prior art date
Application number
FI970114A
Other languages
English (en)
Swedish (sv)
Other versions
FI970114A (fi
Inventor
Andrees Bohme
Didier Branellec
Patrice Denefle
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI970114A0 publication Critical patent/FI970114A0/fi
Publication of FI970114A publication Critical patent/FI970114A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
    • C12N9/0075—Nitric-oxide synthase (1.14.13.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
    • C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
FI970114A 1994-07-12 1997-01-10 NO-syntaasia koodaavan geenin käsittävä adenovirus FI970114A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9408657A FR2722507B1 (fr) 1994-07-12 1994-07-12 Adenovirus comportant un gene codant pour une no synthase
PCT/FR1995/000913 WO1996001902A1 (fr) 1994-07-12 1995-07-07 Adenovirus comportant un gene codant pour une no synthase

Publications (2)

Publication Number Publication Date
FI970114A0 true FI970114A0 (fi) 1997-01-10
FI970114A FI970114A (fi) 1997-01-10

Family

ID=9465319

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970114A FI970114A (fi) 1994-07-12 1997-01-10 NO-syntaasia koodaavan geenin käsittävä adenovirus

Country Status (11)

Country Link
EP (1) EP0770133A1 (fi)
JP (1) JPH10502533A (fi)
AU (1) AU691008B2 (fi)
CA (1) CA2193263A1 (fi)
FI (1) FI970114A (fi)
FR (1) FR2722507B1 (fi)
IL (1) IL114565A0 (fi)
MX (1) MX9700298A (fi)
NO (1) NO970048L (fi)
WO (1) WO1996001902A1 (fi)
ZA (1) ZA955797B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833651A (en) * 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents
WO1999041398A1 (en) * 1998-02-11 1999-08-19 Genvec, Inc. Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
US6206914B1 (en) 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
EP1020520A1 (en) * 1999-01-15 2000-07-19 Introgene B.V. Prevention of immune related removal of cells from the mammalian body, mutant PML molecules useful therefor
SK14692001A3 (sk) * 1999-04-16 2002-09-10 Yale University Izolovaná molekula nukleovej kyseliny, izolovaný NOS polypeptid, spôsob stimulácie, spôsob liečby, spôsob identifikácie a nehumánne transgénne zviera
FR2793142A1 (fr) * 1999-05-04 2000-11-10 Aventis Pharma Sa Utilisation d'oligonucleotides antisens de no-synthase inductible dans la prevention et le traitement de l'ischemie cerebrale
AU5081200A (en) * 1999-05-04 2000-11-17 Aventis Pharma S.A. Use of inducible no-synthase antisense oligonucleotides for preventing and treating cerebral ischemia
EP1067190A1 (en) * 1999-07-09 2001-01-10 Introgene B.V. Gene therapy for enhancing and/or inducing angiogenesis
EP1076091A1 (en) * 1999-08-09 2001-02-14 Universite Catholique De Louvain Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281627A (en) * 1992-05-28 1994-01-25 Cornell Research Foundation, Inc. Substituted arginines and substituted homoarginines and use thereof
EP0957172B1 (en) * 1992-11-18 2005-10-19 Arch Development Corporation Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
FR2704556B1 (fr) * 1993-04-30 1995-07-13 Rhone Poulenc Rorer Sa Virus recombinants et leur utilisation en thérapie génique.
FR2705361B1 (fr) * 1993-05-18 1995-08-04 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
EP0702518B1 (en) * 1993-06-11 2003-04-02 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
FR2707494B1 (fr) * 1993-07-02 1995-08-25 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
US6682728B1 (en) * 1993-10-13 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Efficient and selective adenoviral-mediated gene transfer into vascular neointima

Also Published As

Publication number Publication date
NO970048D0 (no) 1997-01-07
AU2930695A (en) 1996-02-09
NO970048L (no) 1997-01-07
FR2722507A1 (fr) 1996-01-19
FR2722507B1 (fr) 1996-08-14
CA2193263A1 (fr) 1996-01-25
IL114565A0 (en) 1995-11-27
WO1996001902A1 (fr) 1996-01-25
AU691008B2 (en) 1998-05-07
JPH10502533A (ja) 1998-03-10
MX9700298A (es) 1997-05-31
FI970114A (fi) 1997-01-10
EP0770133A1 (fr) 1997-05-02
ZA955797B (en) 1996-02-26

Similar Documents

Publication Publication Date Title
ID24163A (id) Pemindahan data
BR9808524B1 (pt) codificador magnético.
DE69805403D1 (de) Datenkopierschutz
DE69924542D1 (de) Farbbandkassette
DE69724554D1 (de) Datenübertragungsmechanismus
DE69834391D1 (de) Datentransferverfahren
NO20001788L (no) Kjernebor
FI965231A0 (fi) Adenovirus, joka sisältää superoksidismutaasia koodittavan geenin
DE69808874D1 (de) Druckeranordnung
DE69700741D1 (de) Farbbandkassette
GB2332330B (en) Data encoding system
FI970114A0 (fi) NO-syntaasia koodaavan geenin käsittävä adenovirus
DE69812311D1 (de) Lauflängenkodierung
DE69514876D1 (de) Farbbandkassette
PL340374A1 (en) Tanatin encoding gene
DE59801668D1 (de) Abstandhalter
FI951823A (fi) Oligoamidiepikirohydriini hartsit
DE69524467D1 (de) Seriendrucker
DE69839720D1 (de) Signalformender Datenempfänger
PL338375A1 (en) Spacer
GB9710604D0 (en) Contrast media
DE69832447D1 (de) Gen kodierend für Afadin-1
DE69807174D1 (de) Aufzeichnungsmedium - Übertragungsmechanismus
NO983371D0 (no) Kontrastmedier
DE19781663T1 (de) Datentransferanordnung

Legal Events

Date Code Title Description
MA Patent expired